Vimarsana
Biggest News Aggregation in the World

Miyoung Kim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Miyoung Kim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Miyoung Kim Today - Breaking & Trending Today

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China - Vimarsana News

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

By Andrew Silver SHANGHAI (Reuters) - Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatmen...

Source: kelo.com
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China - Vimarsana News

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight...

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China - Vimarsana News

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

SHANGHAI (Reuters) -Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is estimated to have the world's highest number of people who are overweight or obese. Ozempic won approval from China in 2021 and Novo Nordisk saw sales of the drug in the greater China region double to 4.8 billion Danis...

Source: yahoo.com
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China - Vimarsana News

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

SHANGHAI (Reuters) -Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is estimated to have the world's highest number of people who are overweight or obese. Ozempic won approval from China in 2021 and Novo Nordisk saw sales of the drug in the greater China region double to 4.8 billion Danis...

Source: yahoo.com
Apple's iPhone sales in China jump 52% in April, data shows - Vimarsana News

Apple's iPhone sales in China jump 52% in April, data shows

Apple's smartphone shipments in China rose 52% in April from a year ago, extending a rebound seen in March, according to data from a research firm affiliated the Chinese government. The jump follows a weak performance by the U.S. tech giant in the world's biggest smartphone market earlier this year amid intensifying competition in the high-end smartphone category from local rivals like Huawei. Shipments of foreign-branded phones in China increased by 52% in April to 3.495 million units from 2.301 million a year earlier, data from the China Academy of Information and Communications ...

Source: yahoo.com